Navigation Links
Link found between common sexual infection and risk of aggressive prostate cancer
Date:9/9/2009

A new study from Harvard School of Public Health (HSPH) and Brigham and Women's Hospital researchers has found a strong association between the common sexually transmitted infection, Trichomonas vaginalis, and risk of advanced and lethal prostate cancer in men.

The study appears online on September 9, 2009, on the Journal of the National Cancer Institute website and will appear in a later print edition.

"Prostate cancer is the most common cancer among men in western countries, and the second leading cause of cancer-specific mortality. Identifying modifiable risk factors for the lethal form of prostate cancer offers the greatest opportunity to reduce suffering from this disease," said Jennifer Stark, an HSPH researcher and lead author of the study.

One potential risk factor is inflammation, which appears to play an important role in the development and progression of prostate cancer, but the source of inflammation of the prostate is not clear. Trichomonas vaginalis, which infects an estimated 174 million people globally each year and is the most common non-viral sexually transmitted infection, can infect the prostate and could be a source of inflammation. With respect to prostate cancer prevention, it is noteworthy that up to three-quarters of men infected with Trichomonas vaginalis may not realize they are infected, since they may not have any symptoms.

A previous study had found an association between risk of prostate cancer and Trichomonas vaginalis infection, but was not large enough to determine if there was a link between the infection and advanced and lethal disease.

In the present study, the researchers analyzed blood samples from 673 men with prostate cancer who were participants in the Physicians' Health Study and compared infection status based on antibody levels to 673 control subjects who were not diagnosed with prostate cancer. The blood samples were collected i
'/>"/>

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-3952
Harvard School of Public Health
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New type of adult stem cells found in the prostate may be involved in prostate cancer development
2. Peter G. Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and Higher Costs
3. Alzheimers Drug Discovery Foundation Funds Abiant, Inc. to Develop a Positron Emission Tomography (PET) Imaging Diagnostic for Alzheimers Disease
4. Safe Blood for Africa Foundation and Hema-Quebec Sign Far-Reaching Agreement
5. COSHAR Foundation Promotes Importance of Timely Childhood Immunization at Black Family Reunion Celebration in Washington, D.C.
6. Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
7. Migraine Research Foundation Announces Winners of 2009 Research Grants
8. The Sebastian Ferrero Foundation Receives a $5 Million Gift From Google Executive for Childrens Hospital
9. Back to School Brings Risks to Young Drivers; Traffic Crashes Leading Cause of Teen Death, Says National Road Safety Foundation
10. Skin Cancer Worrying You? Us too, Which Is Why Cerjo-USA Is Helping the Skin Cancer Foundation
11. Regence Foundation Awards Nearly $250,000 in Grants to Northwest Nonprofits

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...SUR-SEINE,France,Nov.27/PRNewswire/--TeamGarmin-Sl...dicatedtoethicalsportinganddevelopingthenextgenera...omeTeamGarmin-TransitionswiththeadditionofTransiti...listheworld,sleadingmanufacturerofadaptiveeyewear,...widestselectionofspectaclelensessuchasTransitionsl...
(Date:11/27/2009)... bring unprecedented medical, economic burdens, st...Day News) -- The number of people with diabetes in...next 25 years, a new study predicts. , That wou...eople with the disease, up from 23.7 million today...ple with diabetes will triple, the study also warn...
(Date:11/27/2009)... Specialist manufacturers who use medical...ing millions of dollars by bringing in technology ...asing numbers of pro-active medical manufacturers ...ncept stage of their projects, ensuring that progr...cesses or potentially outdated technology. , ...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
(Date:11/26/2009)... No more letters from the North Pole, Tex...ext messages from Santa , ...e operational efficiencies at the North Pole Santa...hildren all over the globe informed of his Christm...rsquo;s research department have identified a larg...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...al Systems (NYSE: VAR ) announced today that it ...ar 2009 following the close of regular trading on ... be followed by a teleconference available to all ...formation on the conference call webcast will be a...
...rvices are not being provided in Zimbabwe. The pub...her communicable diseases are rampant. Staggering ...ges of food and fuel. Estimates are that 300,000 p...ak has claimed over 600 lives. , , InterActi...
...treatment, elective procedures, study says , ...could be a shortage of 1,300 general surgeons in t...shortage could increase to 6,000 by 2050, a new Oh...y departments. A shortage of general surgeons mean...
...anical Council (ABC) has officially launched its A... http://www.themeaningoftea.com ) adoption of tea ...ea Dragon Films will provide ABC financial support...ase, one of the most robust and powerful herbal da...
...e will feature two of the most innovative new voic...Activism Week and Personhood Conference Jan. 21-23.../prnh/20081105/DC44231LOGO ) , , The TAW will...d Lila Rose, the UCLA student president of Live ...
...evelop the disease within 5 years, study finds , ...ong people whose brain scans show signs of multipl...ll develop MS within about five years, researchers...lities similar to those that occur in MS. After th...
Other Medicine News:Health News:Varian Medical Systems Schedules First Quarter FY2009 News Release and Conference Call 2Health News:Varian Medical Systems Schedules First Quarter FY2009 News Release and Conference Call 3Health News:U.S. May Soon Face Shortage of General Surgeons 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 3Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 4Health News:A.L.L. Personhood Conference Features Pro-Life New Media Stars 2Health News:MRI Can Spot Presymptomatic MS 2
(Date:11/25/2009)....25/PRNewswire/-- ChemoCentryx,Inc.,announcedtoda...T-1(theProspectiveRandomizedOralTherapyEvaluationi...patientswithmoderate-to-severeCrohn,sdiseasedemons...abilityprofile.Thestudydemonstratedevidenceofclini...dasa70-pointdecreaseintheCrohn,sDiseaseActivityInd...
(Date:11/24/2009)...ewswire-FirstCall/--QuestDiagnosticsIncorporated(N...sting,informationandservices,announcedthatitissche...onferenceinNewYorkCity.Thepresentationisscheduledf..., Duringtheconference,thecompanywillreaffirmits...ingincometoexceed18%ofrevenues,anddilutedearningsp...
(Date:11/24/2009)...wswire/--Inadditiontofamily,friendsandhealth,cance...herThanksgivinggratitudelist. ,, "Theyheardthef...aidofMonday,sverdictstotaling$103millionindamagesa...2,000womennationwidewhohavesuedWyethandPfizerpharm...ndPrempro.Wisneskiandtheothervictimsofhormonethera...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin 56921 1Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin 56921 2Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 1Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 2Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 3AOBO Launches New OTC Product to Treat Throat Inflammation 14001 1AOBO Launches New OTC Product to Treat Throat Inflammation 14001 2
...al , AUSTIN, Texas--(BUSINESS WIRE)--May 30, 2007-...ed today the publication of,data describing the dr...n in a patient with a rare inherited form of cance...isorder characterized by,inherited mutations in th...orted treatment of Li-Fraumeni tumors with a thera...
...2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today a...udy of aztreonam lysine for inhalation for,the tre...e,pulmonary Pseudomonas aeruginosa (P. aeruginosa)...y 28 from baseline in respiratory,symptoms, as ass...,(CFQ-R), a patient-reported outcome (PRO) tool us...
Other Medicine Technology:Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 2Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 3Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 5
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: